Subconjunctival Bevacizumab Injection in Glaucoma Filtering Surgery: A Case Control Series

Table 4

Comparison in the reduction of IOP and medications in both subconjunctival bevacizumab (SCB) and control groups.

	SCB group; 𝑁=30	Control group; 𝑁=30	𝑃 value
Final IOP; (mmHg)	14.0 ± 4.7	11.9 ± 4.7	0.36
Percentage of IOP reduction	20%	36%	0.73
Final number of medications	0.7 ± 1.1	0.4 ± 0.8	0.11
Percentage of the reduction of medication use	32%	27%	0.15